• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Advanced Viral Research Corp

ADVR:US

Ticker Delisted

Snapshot for Advanced Viral Research Corp (ADVR)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for ADVR

No chart data available.
  • ADVR:US
  • 1M
  • 1Y
0.0000
Interactive ADVR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ADVR

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0020
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 880.71
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ADVR

No data available

Company Profile & Key Executives for ADVR

Advanced Viral Research Corp. is developing Reticulose, an anti-viral peptide nucleic acid preparation, for the treatment of certain viral diseases. The Company is currently conducting research, in vitro testing, and analysis of its product in the United States.

Stephen M EllistonPresident/CEO
More Company Profile & Key Executives for ADVR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil